Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
5.59
+0.09 (1.64%)
Dec 18, 2025, 3:02 PM EST - Market open
Immuneering Market Cap
Immuneering has a market cap or net worth of $360.95 million as of December 18, 2025. Its market cap has increased by 453.55% in one year.
Market Cap
360.95M
Enterprise Value
152.80M
1-Year Change
453.55%
Ranking
Category
Stock Price
$5.59
Market Cap Chart
Since the IPO on July 30, 2021, Immuneering's market cap has decreased from $365.84M to $360.95M, a decrease of -1.34%. That is a compound annual growth rate of -0.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 17, 2025 | 355.13M | 419.88% |
| Dec 31, 2024 | 68.31M | -68.25% |
| Dec 29, 2023 | 215.13M | 67.99% |
| Dec 30, 2022 | 128.06M | -69.91% |
| Dec 31, 2021 | 425.60M | 16.33% |
| Jul 30, 2021 | 365.84M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 932.80B |
| Johnson & Johnson | 506.75B |
| AbbVie | 396.44B |
| UnitedHealth Group | 300.40B |
| AstraZeneca | 281.50B |
| Novartis AG | 260.63B |
| Merck & Co. | 246.17B |
| Abbott Laboratories | 220.33B |